Granite Point Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Granite Point Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-43,750	Closed	-$1.17M	–	118
2017 Q1	$1.17M	Sell	43,750 -16,500	-27%	-$456K	0.35%	41
2016 Q4	$1.58M	Hold	60,250	–	–	1.26%	27
2016 Q3	$1.51M	Sell	60,250 -6,700	-10%	-$156K	0.59%	30
2016 Q2	$1.45M	Buy	+66,950	New	+$1.19M	0.62%	26
2015 Q2	–	Sell	-45,000	Closed	-$779K	–	124
2015 Q1	$779K	Hold	45,000	–	–	0.29%	58
2014 Q4	$807K	Sell	45,000 -5,000	-10%	-$80.5K	0.38%	48
2014 Q3	$657K	Buy	+50,000	New	+$673K	0.33%	55

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Granite Point Capital Management's NXTM Position: Q2 2017 in Review

Granite Point Capital Management sold out of NxStage Medical Inc. (NXTM) in Q2 2017, closing a stake of 43,750 shares — an estimated $1.17M sold.

Granite Point Capital Management first reported a position in NXTM in Q3 2014 and held it in 7 quarters. The position peaked at $1.58M in Q4 2016. 163 funds tracked by Wall St. Rank hold NXTM as of Q2 2017.

Granite Point Capital Management reported no remaining NxStage Medical Inc. position as of Q2 2017 after selling out during the quarter.
Granite Point Capital Management sold 43,750 NxStage Medical Inc. shares in Q2 2017, an estimated $1.17M.
Granite Point Capital Management first reported a position in NxStage Medical Inc. in Q3 2014 and held it in 7 quarters.
Granite Point Capital Management's NxStage Medical Inc. position peaked at $1.58M in Q4 2016.
163 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2017.

Based on Granite Point Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.